Healthcare
Omnes and Parquest sell Vivalto to CDC et al.
Clinic operator was created via MBO in 2009
Bridges’ Alina bolts on Extra Mile Care
Acquisition of domiciliary care business marks third bold-on for Alina with Bridges backing
Deal in Focus: IK’s Attendo finds happy home on Stockholm exchange
The care home operator's IPO was warmly welcomed by investors, despite operating in a sector sometimes seen as controversial in Sweden
SHS acquires SIS-Schwager Group
GP closed fourth fund on €125m in May
VC-backed Kuros merges with listed Cytos
Kuros recently raised CHF 20m
Industrifonden leads SEK 24m fundraising for Athera
Exit features earn-out for seller Karolinska Development
GHO buys Quotient Clinical from BDC
BDC exits drug development business after two years, reaps 6.4x money multiple and strong IRR
Kesios raises £19m series-A from Abingworth et al.
Kesios span out of Imperial College in July 2012
BaltCap acquires 56% of DIE
Balance of shares to be held by management and key employees
IK's Attendo soars following SEK 8bn IPO in Stockholm
Share price hits SEK 73 per share after introduction at SEK 50
HTGF-backed Bomedus raises €2.5m series-B
Company is spinout from University Clinic of Bonn
Monsanto et al. in €5.7m series-A for PlantResponse
Business to reinforce R&D ranks with new hires
HBM backs Obseva’s CHF 60m series-B
Company develops drugs for reproductive health
21 Partners-backed Synerlab acquires Alcalá Farma
Alcalá was founded in 1995
Molecular Health raises €25m from Dievini
Biotech company has sites in Germany and the US
Foresight invests £4.5m in Hospital Services Limited
Capital was drawn from three Foresight VCT funds
Ardian’s Riemser bolts on Intrapharm
Intrapharm had acquired Peckforton in 2014
Transplant raises €1.5m from Kereon et al.
Funds to back commercial launch of organ transportation system
Ovizio raises €8m from NSV et al.
VC's second foray in Belgian healthcare in recent months
Vaaka adds six companies to Fysios platform
Buy-and-build group expands presence in Finland
LifeCare-backed Kuros raises CHF 5m extension
Company has been developing biomaterials since 2000
NightstaRX raises $35m series B
Funding round was also joined by Syncona
IK Investment Partners’ Attendo seeks SEK 8bn Stockholm IPO
Care company is expected to list on 30 November
HgCapital exits Casa Reha to Korian in trade sale
Two investments left in HgCapital 5 portfolio